Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

THE UNIVERSITY OF QUEENSLAND

🇦🇺Australia

Country: 🇦🇺Australia

Ownership: Private

Established: 1909-01-01

Employees: 5K

Market Cap: -

Website: http://www.uq.edu.au

Clinical Trials

Targeting Metabolic Flexibility in Amyotrophic Lateral Sclerosis (ALS)

Phase 2

Completed

Conditions: Motor Neuron Disease
Amyotrophic Lateral Sclerosis

Interventions: Drug: Trimetazidine Dihydrochloride

First Posted Date: 2021-03-09

Last Posted Date: 2023-07-20

Lead Sponsor: The University of Queensland

Target Recruit Count: 21

Registration Number: NCT04788745

Locations: 🇦🇺
Royal Brisbane & Women's Hospital, Brisbane, Queensland, Australia
🇳🇱
University Medical Centre Utrecht, Utrecht, Netherlands
🇬🇧
King's College London, London, United Kingdom

Mindfulness Meditation Versus Clinical Hypnosis for Acute, Experimental Pain

Phase 2

Completed

Conditions: Clinical Hypnosis
Mindfulness Meditation

Interventions: Behavioral: Clinical hypnosis
Behavioral: Mindfulness meditation

First Posted Date: 2021-03-08

Last Posted Date: 2023-12-04

Lead Sponsor: The University of Queensland

Target Recruit Count: 105

Registration Number: NCT04786405

Locations: 🇦🇺
The University of Queensland, Brisbane, Queensland, Australia

Food or Supplemental Lutein Absorption

Phase 1

Withdrawn

Conditions: Macula Lutea Opacity

Interventions: Other: Food, blended
Other: Food, unprocessed
Dietary Supplement: Lutein supplement

First Posted Date: 2021-03-08

Last Posted Date: 2021-07-12

Lead Sponsor: The University of Queensland

Registration Number: NCT04786392

Locations: 🇦🇺
School of Human Movement and Nutrition Sciences, The University of Queensland, Saint Lucia, Queensland, Australia

Online Validation of Dietary Intake Food Frequency Questionnaire Over Four Weeks, and Electronic Device Use Questionnaire Over Eight Weeks.

Completed

Conditions: Lutein and Zeaxanthin Dietary Intake
Blue Light Exposure
Age Related Macular Degeneration
Electronic Device Use

Interventions: Other: Weekly Food Frequency Questionnaire
Other: Electronic Device Use Questionnaire
Other: Monthly Food Frequency Questionnaire
Other: 24-Hour Electronic Device Use Diary
Other: 24-Hour Diet Recall

First Posted Date: 2021-03-03

Last Posted Date: 2023-05-22

Lead Sponsor: The University of Queensland

Target Recruit Count: 183

Registration Number: NCT04779411

Locations: 🇦🇺
University of Queensland, St Lucia, Queensland, Australia

Association of MPOD Values With Blue Light.

Completed

Conditions: Age Related Macular Degeneration

First Posted Date: 2021-03-03

Last Posted Date: 2022-05-19

Lead Sponsor: The University of Queensland

Target Recruit Count: 96

Registration Number: NCT04779398

Locations: 🇦🇺
School of Human Movement and Nutrition Sciences, The University of Queensland, Saint Lucia, Queensland, Australia

A Multimodal Intervention to Optimise Antimicrobial Use in Residential Aged Care Facilities (ENGAGEMENT Study)

Not Applicable

Conditions: Antibiotics Causing Adverse Effects in Therapeutic Use
Antimicrobial Stewardship

Interventions: Behavioral: Antimicrobial Stewardship ENGAGEMENT bundle

First Posted Date: 2021-01-12

Last Posted Date: 2021-10-14

Lead Sponsor: The University of Queensland

Target Recruit Count: 18

Registration Number: NCT04705259

Locations: 🇦🇺
Bethany Christian Care, Eight Mile Plains, Queensland, Australia
🇦🇺
Carinity Aged Care, Mitchelton, Queensland, Australia
🇦🇺
Beaumont Care, Rothwell, Queensland, Australia

and more 1 locations

Aerobic Exercise and Sensorimotor Adaptation in Chronic Stroke

Not Applicable

Completed

Conditions: Stroke

Interventions: Behavioral: Treadmill

First Posted Date: 2020-12-08

Last Posted Date: 2020-12-08

Lead Sponsor: The University of Queensland

Target Recruit Count: 20

Registration Number: NCT04657029

Locations: 🇦🇺
The University of Queensland, Brisbane, Queensland, Australia

Uncovering a Novel Therapeutic Target to Reduce Dementia Risk in Parkinson's Disease

Phase 2

Recruiting

Conditions: Memory Impairment
Parkinson Disease
Mild Cognitive Impairment

Interventions: Drug: Placebo
Drug: Levetiracetam

First Posted Date: 2020-11-25

Last Posted Date: 2022-11-04

Lead Sponsor: The University of Queensland

Target Recruit Count: 28

Registration Number: NCT04643327

Locations: 🇦🇺
University of Queensland Centre for Clinical Research, Brisbane, Queensland, Australia

The TELO-SCOPE Study: Attenuating Telomere Attrition With Danazol. Is There Scope to Dramatically Improve Health Outcomes for Adults and Children With Pulmonary Fibrosis

Phase 2

Recruiting

Conditions: Pulmonary Fibrosis
Telomere Shortening
Telomere Disease
Dyskeratosis Congenita

Interventions: Drug: Placebo
Drug: Danazol

First Posted Date: 2020-11-20

Last Posted Date: 2024-01-23

Lead Sponsor: The University of Queensland

Target Recruit Count: 50

Registration Number: NCT04638517

Locations: 🇦🇺
John Hunter Hospital, Newcastle, New South Wales, Australia
🇦🇺
Sydney Children's Hospital, Sydney, New South Wales, Australia
🇦🇺
Royal Prince Alfred Hospital, Sydney, New South Wales, Australia

and more 6 locations

Combined Gut-brain Therapy for Children With Autism

Not Applicable

Completed

Conditions: Functional Gastrointestinal Disorders
Anxiety
Autism Spectrum Disorder
Neurodevelopmental Disorders

Interventions: Combination Product: Synbiotic
Behavioral: Gut-directed Hypnotherapy

First Posted Date: 2020-11-20

Last Posted Date: 2023-09-06

Lead Sponsor: The University of Queensland

Target Recruit Count: 40

Registration Number: NCT04639141

Locations: 🇦🇺
University of Queensland, Child Health Research Centre, Faculty of Medicine, Brisbane, Queensland, Australia

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy